We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Illumina Selected to Support National Genomics Study for Personalized Healthcare in Singapore

By LabMedica International staff writers
Posted on 04 Nov 2026

Singapore’s National Precision Medicine program is using genomic and health data to support more preventive and personalized healthcare. More...

Its latest phase expands beyond healthy volunteers to people with a broad range of medical conditions, examining how genetic differences may influence disease and treatment response. A new national genomics study will now extend whole-genome sequencing to nearly one in 10 residents to help guide the integration of precision medicine into routine care.

Illumina has been selected to provide whole-genome sequencing services for SG-INSIGHT, a cohort under Phase III of Singapore’s National Precision Medicine (NPM) program. The study is expected to include around 450,000 individuals and will combine genomic and health data to generate evidence that could inform more preventive approaches to healthcare. SG-INSIGHT is also intended to support the responsible introduction of genetic screening into Singapore’s public healthcare system and contribute to more personalized care over time.

Sequencing will be performed in Singapore at Illumina’s local genomics facility, where scientific, laboratory, and bioinformatics teams will oversee sample preparation, sequencing, and genomic data analysis. The facility is co-located with Illumina’s manufacturing and research and development operations and will seek the necessary accreditation while complying with Singapore’s Healthcare Services Act 2020. Illumina was selected through an international competitive tender, building on its support for NPM Phase II, PRECISE-SG100K, which involved sequencing more than 100,000 genomes from healthy volunteers.

“Singapore is showing what the future of precision medicine can look like at national scale. By bringing genomic information closer to everyday healthcare, this programme has the potential to advance understanding of disease, generate evidence that supports more informed care decisions, and ultimately move healthcare toward earlier, more precise intervention. We are proud to bring Illumina's technology, expertise and longstanding presence in Singapore to help make that vision possible,” said Jacob Thaysen, Chief Executive Officer of Illumina.

“Phase III builds on nearly a decade of precision medicine in Singapore. By extending the programme to patients across the public healthcare system, SG-INSIGHT aims to deepen understanding of how genetic, lifestyle and environmental factors are associated with health and disease. Phase III reflects Singapore's ambition to build a trusted and sustainable precision health ecosystem grounded in the needs and diversity of its population,” said Professor Patrick Tan, Executive Director of PRECISE.

Related Links
Precision Health Research, Singapore


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.